New study tracks cystic fibrosis drugs in pregnancy and breast milk
NCT ID NCT04940533
First seen Jan 27, 2026 · Last updated Apr 28, 2026 · Updated 13 times
Summary
This study looks at how cystic fibrosis medications (CFTR modulators) change in the body during pregnancy and after birth in breastfeeding women. Researchers will measure drug levels in blood, breast milk, and umbilical cord blood from 30 women. The goal is to understand how these drugs work during pregnancy and while breastfeeding, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.